MedPath

Effect Evaluation of Early Exercise Training After Myocardial Infarction

Phase 2
Completed
Conditions
Myocardial Infarction
Registration Number
NCT00246545
Lead Sponsor
Norwegian University of Science and Technology
Brief Summary

The aim of the study is to evaluate the effect of early onset of exercise training (ET) after myocardial infarction (MI) in a randomized controlled trial. Usual care is to wait 4-6 weeks after onset of MI, and our hypotheses are that early ET will prevent a fall in VO2peak and contribute to better quality of life.

Detailed Description

Exercise training is well documented as effective treatment for myocardial infarction(MI) patients. However, the long time effect of early onset is more unclear, and it is needed to provide knowledge about to which extend early onset of ET contribute to reduce risk factors, increase oxygen consumption and influence on quality of life.

A RCT is conducted, 60 persons with recently MI is invited to participate. The subjects participating is hospitalised in St. Olavs Hospital. The participants are randomised to either a training group or a control group. The training group will be offered hospital out-patient group exercise training of moderate intensity twice a week for four weeks. The training is leaded by a physiotherapist. The control group will wait four weeks before both groups continue ET twice a week for 12 weeks (high intensity training).

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
39
Inclusion Criteria
  • Myocardiac infarction, 2 weeks ago
  • over 18 years
  • able to participate i exercise groups
Exclusion Criteria
  • unstable angina
  • heart failure
  • failure to reach a maximal pretest
  • drug abuse

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Change in maximal oxygen consumption
Secondary Outcome Measures
NameTimeMethod
change in risk factors (smoking habits, physical activity)
quality of life

Trial Locations

Locations (1)

St. Olavs Hospital

🇳🇴

Trondheim, Sør-Trøndelag, Norway

© Copyright 2025. All Rights Reserved by MedPath